Page last updated: 2024-11-06

tryptanthrine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tryptanthrine is a synthetic alkaloid with a complex structure that has attracted attention due to its diverse pharmacological activities. It is a potent inhibitor of various enzymes, including topoisomerase I and II, and exhibits anticancer properties. The compound is also known to interact with DNA, potentially affecting its replication and transcription. Research on tryptanthrine focuses on its potential as a chemotherapeutic agent, particularly for treating leukemia and solid tumors. Further investigation is ongoing to optimize its delivery and improve its therapeutic index. '
```

tryptanthrine: minor constituent of traditional Chinese medicine qing dai [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73549
CHEMBL ID306946
CHEBI ID9768
SCHEMBL ID2426211
MeSH IDM0134074

Synonyms (50)

Synonym
gnf-pf-2691 ,
chebi:9768 ,
CHEMBL306946 ,
nsc 349447
unii-4y6e3f2u66
4y6e3f2u66 ,
indolo(2,1-b)quinazoline-6,12-dione
NCI60_003113
nsc-349447
indolo[2,12-dione
nsc349447
tryptanthrin
smr000386951
MLS001049121
tryptantherin
indolo[2,1-b]quinazoline-6,12-dione
OPREA1_754264
13220-57-0
tryptanthrine
NCGC00160337-02
NCGC00160337-01
6,12-dihydro-6,12-dioxoindole(2,1-b)quinazoline
STK078931
bdbm50240612
TCMDC-125859 ,
AKOS000671350
HMS2271H05
S5686
gtpl8224
couroupitine a
CCG-208326
mfcd00012073
SY017117
SCHEMBL2426211
c15h8n2o2
DTXSID90157431
SR-01000521538-1
sr-01000521538
SR-01000521538-4
tryptanthrin, >=98% (hplc)
J-006143
ncgc00160337-01!tryptanthrine
trypthanthrine
FT-0733127
DS-15687
Q27089028
AMY31414
triptantrin
CS-0034349
HY-N6607

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Tryptanthrin was well absorbed across the Caco-2 monolayers, and its transepithelial transports were dominated by passive diffusion."( Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
Ma, G; Wang, H; Yan, J; Yang, Q; Zhang, X; Zhu, X, 2011
)
0.37
" The orally bioavailable lead imidazolopiperazine confers complete causal prophylactic protection (15 milligrams/kilogram) in rodent models of malaria and shows potent in vivo blood-stage therapeutic activity."( Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y, 2011
)
0.37
" Those with the best potency and oral bioavailability were progressed to evaluations of efficacy against acute murine TB."( Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
Cho, SN; Franzblau, SG; Hwang, JM; Kaneko, T; Kim, P; Ma, Z; Oh, T; Upton, AM, 2013
)
0.39
"Cell membrane permeability is an important determinant for oral absorption and bioavailability of a drug molecule."( Highly predictive and interpretable models for PAMPA permeability.
Jadhav, A; Kerns, E; Nguyen, K; Shah, P; Sun, H; Xu, X; Yan, Z; Yu, KR, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
organonitrogen heterocyclic compoundAny organonitrogen compound containing a cyclic component with nitrogen and at least one other element as ring member atoms.
organic heterotetracyclic compound
alkaloid antibioticAny alkaloid that has significant antibiotic properties.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (36)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency0.89130.044717.8581100.0000AID485294
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency7.09390.140911.194039.8107AID2451
LuciferasePhotinus pyralis (common eastern firefly)Potency21.33130.007215.758889.3584AID588342
ATAD5 protein, partialHomo sapiens (human)Potency1.63530.004110.890331.5287AID504467
TDP1 proteinHomo sapiens (human)Potency0.89440.000811.382244.6684AID686978; AID686979
Microtubule-associated protein tauHomo sapiens (human)Potency17.78280.180013.557439.8107AID1460
Smad3Homo sapiens (human)Potency3.16230.00527.809829.0929AID588855
nonstructural protein 1Influenza A virus (A/WSN/1933(H1N1))Potency1.12200.28189.721235.4813AID2326
67.9K proteinVaccinia virusPotency10.00000.00018.4406100.0000AID720579
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency2.81840.01262.451825.0177AID485313
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency5.84330.00419.984825.9290AID504444; AID720524
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency3.16233.548119.542744.6684AID743266
huntingtin isoform 2Homo sapiens (human)Potency11.22020.000618.41981,122.0200AID1688
ras-related protein Rab-9AHomo sapiens (human)Potency3.16230.00022.621531.4954AID485297
histone-lysine N-methyltransferase 2A isoform 2 precursorHomo sapiens (human)Potency31.62280.010323.856763.0957AID2662
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency89.12510.050127.073689.1251AID588590
urokinase-type plasminogen activator precursorMus musculus (house mouse)Potency2.51190.15855.287912.5893AID540303
plasminogen precursorMus musculus (house mouse)Potency2.51190.15855.287912.5893AID540303
urokinase plasminogen activator surface receptor precursorMus musculus (house mouse)Potency2.51190.15855.287912.5893AID540303
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency11.22020.00798.23321,122.0200AID2551
gemininHomo sapiens (human)Potency1.15820.004611.374133.4983AID624297
VprHuman immunodeficiency virus 1Potency3.54811.584919.626463.0957AID651644
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency1.41250.00419.962528.1838AID2675
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency10.00000.251215.843239.8107AID504327
lamin isoform A-delta10Homo sapiens (human)Potency0.35480.891312.067628.1838AID1487
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)IC50 (µMol)133.38330.00011.68479.3200AID1461764; AID1461765; AID674860
Indoleamine 2,3-dioxygenase 1Homo sapiens (human)IC50 (µMol)10,842.61070.05373.075710.0000AID1053471; AID1053473; AID1461746; AID1639962; AID1639965
Indoleamine 2,3-dioxygenase 1Homo sapiens (human)Ki4.81000.09402.37907.0000AID1053473; AID1639955
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)0.06400.00010.995010.0000AID403340; AID674859; AID717352
Tryptophan 2,3-dioxygenaseHomo sapiens (human)IC50 (µMol)1.29350.11001.66929.8000AID1572836; AID1585053; AID1585056; AID1585057
Tryptophan 2,3-dioxygenaseHomo sapiens (human)Ki0.58100.03000.49700.8800AID1585054
Indoleamine 2,3-dioxygenase 2Homo sapiens (human)IC50 (µMol)11.15501.80003.93675.0100AID1332706; AID1332708; AID1639963; AID1639966
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
recombinase AMycobacterium tuberculosis H37RvEC50 (µMol)0.98400.018023.2882287.6000AID434968; AID435010
High affinity nerve growth factor receptorHomo sapiens (human)Kd9.20000.00201.34849.2000AID1530269
Mitogen-activated protein kinase 8Homo sapiens (human)Kd23.00000.01102.096526.0590AID1530258
BDNF/NT-3 growth factors receptorHomo sapiens (human)Kd7.20000.00380.78757.2000AID1530270
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
replicative DNA helicaseMycobacterium tuberculosis H37RvAC50190.53900.057030.7482325.3000AID449749; AID449750
HSP40, subfamily A [Plasmodium falciparum 3D7]Plasmodium falciparum 3D7AbsAC1000_uM1.83500.12904.116911.3160AID540271
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (203)

Processvia Protein(s)Taxonomy
cellular response to amyloid-betaHigh affinity nerve growth factor receptorHomo sapiens (human)
positive regulation of protein phosphorylationHigh affinity nerve growth factor receptorHomo sapiens (human)
protein phosphorylationHigh affinity nerve growth factor receptorHomo sapiens (human)
axon guidanceHigh affinity nerve growth factor receptorHomo sapiens (human)
learning or memoryHigh affinity nerve growth factor receptorHomo sapiens (human)
circadian rhythmHigh affinity nerve growth factor receptorHomo sapiens (human)
negative regulation of cell population proliferationHigh affinity nerve growth factor receptorHomo sapiens (human)
response to xenobiotic stimulusHigh affinity nerve growth factor receptorHomo sapiens (human)
programmed cell death involved in cell developmentHigh affinity nerve growth factor receptorHomo sapiens (human)
positive regulation of neuron projection developmentHigh affinity nerve growth factor receptorHomo sapiens (human)
peptidyl-tyrosine phosphorylationHigh affinity nerve growth factor receptorHomo sapiens (human)
olfactory nerve developmentHigh affinity nerve growth factor receptorHomo sapiens (human)
B cell differentiationHigh affinity nerve growth factor receptorHomo sapiens (human)
response to nutrient levelsHigh affinity nerve growth factor receptorHomo sapiens (human)
peptidyl-tyrosine autophosphorylationHigh affinity nerve growth factor receptorHomo sapiens (human)
nerve growth factor signaling pathwayHigh affinity nerve growth factor receptorHomo sapiens (human)
mechanoreceptor differentiationHigh affinity nerve growth factor receptorHomo sapiens (human)
negative regulation of apoptotic processHigh affinity nerve growth factor receptorHomo sapiens (human)
positive regulation of programmed cell deathHigh affinity nerve growth factor receptorHomo sapiens (human)
negative regulation of neuron apoptotic processHigh affinity nerve growth factor receptorHomo sapiens (human)
positive regulation of GTPase activityHigh affinity nerve growth factor receptorHomo sapiens (human)
positive regulation of Ras protein signal transductionHigh affinity nerve growth factor receptorHomo sapiens (human)
protein autophosphorylationHigh affinity nerve growth factor receptorHomo sapiens (human)
neurotrophin TRK receptor signaling pathwayHigh affinity nerve growth factor receptorHomo sapiens (human)
ephrin receptor signaling pathwayHigh affinity nerve growth factor receptorHomo sapiens (human)
sympathetic nervous system developmentHigh affinity nerve growth factor receptorHomo sapiens (human)
response to axon injuryHigh affinity nerve growth factor receptorHomo sapiens (human)
detection of temperature stimulus involved in sensory perception of painHigh affinity nerve growth factor receptorHomo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painHigh affinity nerve growth factor receptorHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityHigh affinity nerve growth factor receptorHomo sapiens (human)
neuron apoptotic processHigh affinity nerve growth factor receptorHomo sapiens (human)
response to hydrostatic pressureHigh affinity nerve growth factor receptorHomo sapiens (human)
response to electrical stimulusHigh affinity nerve growth factor receptorHomo sapiens (human)
positive regulation of synapse assemblyHigh affinity nerve growth factor receptorHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicHigh affinity nerve growth factor receptorHomo sapiens (human)
Sertoli cell developmentHigh affinity nerve growth factor receptorHomo sapiens (human)
axonogenesis involved in innervationHigh affinity nerve growth factor receptorHomo sapiens (human)
behavioral response to formalin induced painHigh affinity nerve growth factor receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeHigh affinity nerve growth factor receptorHomo sapiens (human)
cellular response to nicotineHigh affinity nerve growth factor receptorHomo sapiens (human)
cellular response to nerve growth factor stimulusHigh affinity nerve growth factor receptorHomo sapiens (human)
multicellular organism developmentHigh affinity nerve growth factor receptorHomo sapiens (human)
positive regulation of kinase activityHigh affinity nerve growth factor receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayHigh affinity nerve growth factor receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeHigh affinity nerve growth factor receptorHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionHigh affinity nerve growth factor receptorHomo sapiens (human)
negative regulation of endothelial cell proliferationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte chemotaxis involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte migration involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
humoral immune responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of bone mineralizationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
dendritic cell migrationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
glucose homeostasisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
long-chain fatty acid biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of fat cell differentiationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of insulin secretionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of vascular wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory response to woundingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cytokine production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cellular response to oxidative stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene A4 biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of sprouting angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of leukocyte adhesion to arterial endothelial cellPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxin biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of activated T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell tolerance inductionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of chronic inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of type 2 immune responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
female pregnancyIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic process to kynurenineIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
response to lipopolysaccharideIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of interleukin-10 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of interleukin-12 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
multicellular organismal response to stressIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
kynurenic acid biosynthetic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
swimming behaviorIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
'de novo' NAD biosynthetic process from tryptophanIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
JUN phosphorylationMitogen-activated protein kinase 8Homo sapiens (human)
response to UVMitogen-activated protein kinase 8Homo sapiens (human)
negative regulation of apoptotic processMitogen-activated protein kinase 8Homo sapiens (human)
cellular response to lipopolysaccharideMitogen-activated protein kinase 8Homo sapiens (human)
protein phosphorylationMitogen-activated protein kinase 8Homo sapiens (human)
response to oxidative stressMitogen-activated protein kinase 8Homo sapiens (human)
JNK cascadeMitogen-activated protein kinase 8Homo sapiens (human)
JUN phosphorylationMitogen-activated protein kinase 8Homo sapiens (human)
positive regulation of gene expressionMitogen-activated protein kinase 8Homo sapiens (human)
regulation of macroautophagyMitogen-activated protein kinase 8Homo sapiens (human)
peptidyl-serine phosphorylationMitogen-activated protein kinase 8Homo sapiens (human)
peptidyl-threonine phosphorylationMitogen-activated protein kinase 8Homo sapiens (human)
positive regulation of cyclase activityMitogen-activated protein kinase 8Homo sapiens (human)
positive regulation of cell killingMitogen-activated protein kinase 8Homo sapiens (human)
negative regulation of protein bindingMitogen-activated protein kinase 8Homo sapiens (human)
regulation of protein localizationMitogen-activated protein kinase 8Homo sapiens (human)
cellular response to amino acid starvationMitogen-activated protein kinase 8Homo sapiens (human)
cellular response to oxidative stressMitogen-activated protein kinase 8Homo sapiens (human)
cellular response to reactive oxygen speciesMitogen-activated protein kinase 8Homo sapiens (human)
Fc-epsilon receptor signaling pathwayMitogen-activated protein kinase 8Homo sapiens (human)
regulation of circadian rhythmMitogen-activated protein kinase 8Homo sapiens (human)
positive regulation of apoptotic processMitogen-activated protein kinase 8Homo sapiens (human)
negative regulation of apoptotic processMitogen-activated protein kinase 8Homo sapiens (human)
rhythmic processMitogen-activated protein kinase 8Homo sapiens (human)
positive regulation of protein metabolic processMitogen-activated protein kinase 8Homo sapiens (human)
stress-activated MAPK cascadeMitogen-activated protein kinase 8Homo sapiens (human)
cellular response to mechanical stimulusMitogen-activated protein kinase 8Homo sapiens (human)
cellular response to cadmium ionMitogen-activated protein kinase 8Homo sapiens (human)
cellular senescenceMitogen-activated protein kinase 8Homo sapiens (human)
energy homeostasisMitogen-activated protein kinase 8Homo sapiens (human)
positive regulation of NLRP3 inflammasome complex assemblyMitogen-activated protein kinase 8Homo sapiens (human)
response to mechanical stimulusMitogen-activated protein kinase 8Homo sapiens (human)
positive regulation of establishment of protein localization to mitochondrionMitogen-activated protein kinase 8Homo sapiens (human)
tryptophan catabolic process to kynurenineTryptophan 2,3-dioxygenaseHomo sapiens (human)
protein homotetramerizationTryptophan 2,3-dioxygenaseHomo sapiens (human)
response to nitroglycerinTryptophan 2,3-dioxygenaseHomo sapiens (human)
tryptophan catabolic process to acetyl-CoATryptophan 2,3-dioxygenaseHomo sapiens (human)
negative regulation of amyloid-beta formationBDNF/NT-3 growth factors receptorHomo sapiens (human)
vasculogenesisBDNF/NT-3 growth factors receptorHomo sapiens (human)
neuron migrationBDNF/NT-3 growth factors receptorHomo sapiens (human)
positive regulation of protein phosphorylationBDNF/NT-3 growth factors receptorHomo sapiens (human)
learningBDNF/NT-3 growth factors receptorHomo sapiens (human)
circadian rhythmBDNF/NT-3 growth factors receptorHomo sapiens (human)
feeding behaviorBDNF/NT-3 growth factors receptorHomo sapiens (human)
positive regulation of cell population proliferationBDNF/NT-3 growth factors receptorHomo sapiens (human)
positive regulation of gene expressionBDNF/NT-3 growth factors receptorHomo sapiens (human)
positive regulation of neuron projection developmentBDNF/NT-3 growth factors receptorHomo sapiens (human)
glutamate secretionBDNF/NT-3 growth factors receptorHomo sapiens (human)
neuronal action potential propagationBDNF/NT-3 growth factors receptorHomo sapiens (human)
central nervous system neuron developmentBDNF/NT-3 growth factors receptorHomo sapiens (human)
cerebral cortex developmentBDNF/NT-3 growth factors receptorHomo sapiens (human)
myelination in peripheral nervous systemBDNF/NT-3 growth factors receptorHomo sapiens (human)
neuron differentiationBDNF/NT-3 growth factors receptorHomo sapiens (human)
brain-derived neurotrophic factor receptor signaling pathwayBDNF/NT-3 growth factors receptorHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationBDNF/NT-3 growth factors receptorHomo sapiens (human)
neurotrophin signaling pathwayBDNF/NT-3 growth factors receptorHomo sapiens (human)
mechanoreceptor differentiationBDNF/NT-3 growth factors receptorHomo sapiens (human)
regulation of GTPase activityBDNF/NT-3 growth factors receptorHomo sapiens (human)
positive regulation of MAPK cascadeBDNF/NT-3 growth factors receptorHomo sapiens (human)
negative regulation of neuron apoptotic processBDNF/NT-3 growth factors receptorHomo sapiens (human)
retinal rod cell developmentBDNF/NT-3 growth factors receptorHomo sapiens (human)
protein autophosphorylationBDNF/NT-3 growth factors receptorHomo sapiens (human)
oligodendrocyte differentiationBDNF/NT-3 growth factors receptorHomo sapiens (human)
peripheral nervous system neuron developmentBDNF/NT-3 growth factors receptorHomo sapiens (human)
positive regulation of axonogenesisBDNF/NT-3 growth factors receptorHomo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionBDNF/NT-3 growth factors receptorHomo sapiens (human)
positive regulation of synapse assemblyBDNF/NT-3 growth factors receptorHomo sapiens (human)
long-term synaptic potentiationBDNF/NT-3 growth factors receptorHomo sapiens (human)
cellular response to amino acid stimulusBDNF/NT-3 growth factors receptorHomo sapiens (human)
trans-synaptic signaling by BDNF, modulating synaptic transmissionBDNF/NT-3 growth factors receptorHomo sapiens (human)
negative regulation of anoikisBDNF/NT-3 growth factors receptorHomo sapiens (human)
positive regulation of kinase activityBDNF/NT-3 growth factors receptorHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeBDNF/NT-3 growth factors receptorHomo sapiens (human)
multicellular organism developmentBDNF/NT-3 growth factors receptorHomo sapiens (human)
cellular response to brain-derived neurotrophic factor stimulusBDNF/NT-3 growth factors receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayBDNF/NT-3 growth factors receptorHomo sapiens (human)
trans-synaptic signaling by neuropeptide, modulating synaptic transmissionBDNF/NT-3 growth factors receptorHomo sapiens (human)
immune system processIndoleamine 2,3-dioxygenase 2Homo sapiens (human)
tryptophan catabolic process to kynurenineIndoleamine 2,3-dioxygenase 2Homo sapiens (human)
'de novo' NAD biosynthetic process from tryptophanIndoleamine 2,3-dioxygenase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (39)

Processvia Protein(s)Taxonomy
protein tyrosine kinase activityHigh affinity nerve growth factor receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activityHigh affinity nerve growth factor receptorHomo sapiens (human)
GPI-linked ephrin receptor activityHigh affinity nerve growth factor receptorHomo sapiens (human)
neurotrophin p75 receptor bindingHigh affinity nerve growth factor receptorHomo sapiens (human)
protein bindingHigh affinity nerve growth factor receptorHomo sapiens (human)
ATP bindingHigh affinity nerve growth factor receptorHomo sapiens (human)
nerve growth factor receptor activityHigh affinity nerve growth factor receptorHomo sapiens (human)
kinase bindingHigh affinity nerve growth factor receptorHomo sapiens (human)
identical protein bindingHigh affinity nerve growth factor receptorHomo sapiens (human)
protein homodimerization activityHigh affinity nerve growth factor receptorHomo sapiens (human)
nerve growth factor bindingHigh affinity nerve growth factor receptorHomo sapiens (human)
neurotrophin bindingHigh affinity nerve growth factor receptorHomo sapiens (human)
neurotrophin receptor activityHigh affinity nerve growth factor receptorHomo sapiens (human)
arachidonate 5-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 12(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
iron ion bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
protein bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
hydrolase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
electron transfer activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
heme bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
indoleamine 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
metal ion bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
protein serine/threonine kinase activityMitogen-activated protein kinase 8Homo sapiens (human)
JUN kinase activityMitogen-activated protein kinase 8Homo sapiens (human)
protein bindingMitogen-activated protein kinase 8Homo sapiens (human)
ATP bindingMitogen-activated protein kinase 8Homo sapiens (human)
enzyme bindingMitogen-activated protein kinase 8Homo sapiens (human)
protein phosphatase bindingMitogen-activated protein kinase 8Homo sapiens (human)
histone deacetylase regulator activityMitogen-activated protein kinase 8Homo sapiens (human)
histone deacetylase bindingMitogen-activated protein kinase 8Homo sapiens (human)
protein serine kinase activityMitogen-activated protein kinase 8Homo sapiens (human)
protein serine/threonine kinase bindingMitogen-activated protein kinase 8Homo sapiens (human)
tryptophan 2,3-dioxygenase activityTryptophan 2,3-dioxygenaseHomo sapiens (human)
protein bindingTryptophan 2,3-dioxygenaseHomo sapiens (human)
amino acid bindingTryptophan 2,3-dioxygenaseHomo sapiens (human)
oxygen bindingTryptophan 2,3-dioxygenaseHomo sapiens (human)
heme bindingTryptophan 2,3-dioxygenaseHomo sapiens (human)
identical protein bindingTryptophan 2,3-dioxygenaseHomo sapiens (human)
metal ion bindingTryptophan 2,3-dioxygenaseHomo sapiens (human)
protease bindingBDNF/NT-3 growth factors receptorHomo sapiens (human)
protein bindingBDNF/NT-3 growth factors receptorHomo sapiens (human)
ATP bindingBDNF/NT-3 growth factors receptorHomo sapiens (human)
protein homodimerization activityBDNF/NT-3 growth factors receptorHomo sapiens (human)
neurotrophin bindingBDNF/NT-3 growth factors receptorHomo sapiens (human)
brain-derived neurotrophic factor bindingBDNF/NT-3 growth factors receptorHomo sapiens (human)
brain-derived neurotrophic factor receptor activityBDNF/NT-3 growth factors receptorHomo sapiens (human)
heme bindingIndoleamine 2,3-dioxygenase 2Homo sapiens (human)
indoleamine 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 2Homo sapiens (human)
metal ion bindingIndoleamine 2,3-dioxygenase 2Homo sapiens (human)
tryptophan 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (41)

Processvia Protein(s)Taxonomy
early endosomeHigh affinity nerve growth factor receptorHomo sapiens (human)
late endosomeHigh affinity nerve growth factor receptorHomo sapiens (human)
plasma membraneHigh affinity nerve growth factor receptorHomo sapiens (human)
cell surfaceHigh affinity nerve growth factor receptorHomo sapiens (human)
endosome membraneHigh affinity nerve growth factor receptorHomo sapiens (human)
dendriteHigh affinity nerve growth factor receptorHomo sapiens (human)
early endosome membraneHigh affinity nerve growth factor receptorHomo sapiens (human)
late endosome membraneHigh affinity nerve growth factor receptorHomo sapiens (human)
neuronal cell bodyHigh affinity nerve growth factor receptorHomo sapiens (human)
recycling endosome membraneHigh affinity nerve growth factor receptorHomo sapiens (human)
protein-containing complexHigh affinity nerve growth factor receptorHomo sapiens (human)
receptor complexHigh affinity nerve growth factor receptorHomo sapiens (human)
axonHigh affinity nerve growth factor receptorHomo sapiens (human)
plasma membraneHigh affinity nerve growth factor receptorHomo sapiens (human)
extracellular regionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
extracellular spacePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelope lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nucleoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytosolPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear matrixPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear membranePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
secretory granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
perinuclear region of cytoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
ficolin-1-rich granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytosolIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
smooth muscle contractile fiberIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
stereocilium bundleIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
cytoplasmIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmMitogen-activated protein kinase 8Homo sapiens (human)
nucleusMitogen-activated protein kinase 8Homo sapiens (human)
nucleoplasmMitogen-activated protein kinase 8Homo sapiens (human)
cytosolMitogen-activated protein kinase 8Homo sapiens (human)
axonMitogen-activated protein kinase 8Homo sapiens (human)
synapseMitogen-activated protein kinase 8Homo sapiens (human)
basal dendriteMitogen-activated protein kinase 8Homo sapiens (human)
nucleusMitogen-activated protein kinase 8Homo sapiens (human)
cytosolTryptophan 2,3-dioxygenaseHomo sapiens (human)
early endosomeBDNF/NT-3 growth factors receptorHomo sapiens (human)
cytosolBDNF/NT-3 growth factors receptorHomo sapiens (human)
plasma membraneBDNF/NT-3 growth factors receptorHomo sapiens (human)
postsynaptic densityBDNF/NT-3 growth factors receptorHomo sapiens (human)
axonBDNF/NT-3 growth factors receptorHomo sapiens (human)
dendriteBDNF/NT-3 growth factors receptorHomo sapiens (human)
early endosome membraneBDNF/NT-3 growth factors receptorHomo sapiens (human)
terminal boutonBDNF/NT-3 growth factors receptorHomo sapiens (human)
perinuclear region of cytoplasmBDNF/NT-3 growth factors receptorHomo sapiens (human)
receptor complexBDNF/NT-3 growth factors receptorHomo sapiens (human)
axon terminusBDNF/NT-3 growth factors receptorHomo sapiens (human)
plasma membraneBDNF/NT-3 growth factors receptorHomo sapiens (human)
postsynaptic densityBDNF/NT-3 growth factors receptorHomo sapiens (human)
axonBDNF/NT-3 growth factors receptorHomo sapiens (human)
dendritic spineBDNF/NT-3 growth factors receptorHomo sapiens (human)
cytoplasmIndoleamine 2,3-dioxygenase 2Homo sapiens (human)
cytosolIndoleamine 2,3-dioxygenase 2Homo sapiens (human)
cytoplasmIndoleamine 2,3-dioxygenase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (166)

Assay IDTitleYearJournalArticle
AID1645848NCATS Kinetic Aqueous Solubility Profiling2019Bioorganic & medicinal chemistry, 07-15, Volume: 27, Issue:14
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1508612NCATS Parallel Artificial Membrane Permeability Assay (PAMPA) Profiling2017Bioorganic & medicinal chemistry, 02-01, Volume: 25, Issue:3
Highly predictive and interpretable models for PAMPA permeability.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347087qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Confirmatory Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347081qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Confirmatory Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1508591NCATS Rat Liver Microsome Stability Profiling2020Scientific reports, 11-26, Volume: 10, Issue:1
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
AID1347084qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Confirmatory Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347088qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): Viability assay - Alamar blue signal for LCMV Confirmatory Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID739525Inhibition of human recombinant CYP2C19 at 10 uM incubated for 60 mins at 37 degC using 3-cyano-7-ethoxycoumarin substrate2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID1530270Binding affinity to human partial length TRKB (Q547 to G838 residues) expressed in HEK293 cells measured after 1 hr by Kinomescan method2019European journal of medicinal chemistry, Jan-01, Volume: 161Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
AID1612293Antitubercular activity against Mycobacterium tuberculosis H37Rv2019Journal of natural products, 03-22, Volume: 82, Issue:3
Isolation of Tryptanthrin and Reassessment of Evidence for Its Isobaric Isostere Wrightiadione in Plants of the Wrightia Genus.
AID1461774Anti-inflammatory activity in Wistar Han rat assessed as reduction in carrageenan-induced exudate volume at 10 mg/kg, po administered 1 hr prior to carrageenan challenge2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1461745Antiproliferative activity against human MOLT4 cells after 48 hrs2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID674372Cytotoxicity against human A549 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID674867Cytotoxicity against human DU145 cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Synthesis of benzo-annulated tryptanthrins and their biological properties.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1572836Inhibition of TDO (unknown origin)2019Bioorganic & medicinal chemistry, 03-15, Volume: 27, Issue:6
4,6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors.
AID1461742Antiproliferative activity against human MOLT4 cells after 24 hrs2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1461768Anti-inflammatory activity in Wistar Han rat assessed as reduction of carrageenan-induced PGE2 levels at 10 mg/kg, po administered 1 hr prior to carrageenan challenge by radioimmunoassay2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1461754Inhibition of EGF-induced HGF production in HDF at 2 mg/ml after 72 hrs by ELISA2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID739528Permeability across apical to basolateral side in human Caco2 cells incubated for 1 hr at 37 degC by HPLC-MS/MS method2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID739533Cytotoxicity against african green monkey Vero cells2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID1703886Solubility of compound in water2020European journal of medicinal chemistry, Sep-15, Volume: 202Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer.
AID405961Cytotoxicity against human MCF7 cells2008Journal of natural products, Jul, Volume: 71, Issue:7
Isolation, structure elucidation, and synthesis of cytotoxic tryptanthrin analogues from Phaius mishmensis.
AID1530263Binding affinity to human partial length JNK3 (V28 to Q422 residues) expressed in HEK293 cells at <40 uM after 1 hr by Kinomescan method2019European journal of medicinal chemistry, Jan-01, Volume: 161Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
AID481429Inhibition of human topoisomerase 1-mediated relaxation of circular DNA2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antimicrobial activity of tryptanthrins in Escherichia coli.
AID1332712Potency index, ratio of D-1-methyl-tryptophan IC50 to compound IC50 for recombinant human IDO2 expressed in human U87MG cells2016European journal of medicinal chemistry, Nov-10, Volume: 123Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.
AID1243392Antimycobacterial activity against multi-drug resistant Mycobacterium tuberculosis2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents.
AID1461750Induction of apoptosis in human K562 cells assessed as late apoptotic cells at 6.25 ug/ml by Annexin V/propidium iodide staining-based flow cytometry2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID674377Cytotoxicity against human HCT8 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1332708Inhibition of recombinant human IDO2 expressed in human U87MG cells assessed as reduction in kynurenine formation using L-tryptophan as substrate after 6 hrs by spectrophotometry2016European journal of medicinal chemistry, Nov-10, Volume: 123Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.
AID1530275Inhibition of JNK in human MONO-MAC-6 cells assessed as reduction in LPS-induced IL6 production at <40 uM preincubated for 30 mins followed by LPS-stimulation and measured after 24 hrs by ELISA2019European journal of medicinal chemistry, Jan-01, Volume: 161Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
AID1585053Inhibition of recombinant full length C-terminal His-tagged human TDO expressed in Escherichia coli using L-Trp as substrate after 30 mins2018European journal of medicinal chemistry, Dec-05, Volume: 160Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID739526Inhibition of human recombinant CYP2C9 at 10 uM incubated for 80 mins at 37 degC using 7-methoxy-4-trifluoromethylcoumarin substrate2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID195107Tested for in vitro cytotoxic activity against renal A498 human cancer cell lines2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationship.
AID1461769Anti-inflammatory activity in Wistar Han rat assessed as reduction in carrageenan-induced increase in infiltrating cells at 10 mg/kg, po administered 1 hr prior to carrageenan challenge by vital trypan blue staining-based microscopic method2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1530273Inhibition of JNK in human THP1-Blue cells assessed as reduction in LPS-induced NFkappaB/AP1 activation at <40 uM preincubated for 30 mins followed by LPS-stimulation and measured after 24 hrs by quanti-blue staining based alkaline phosphatase reporter ge2019European journal of medicinal chemistry, Jan-01, Volume: 161Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
AID739536Antitubercular activity against Mycobacterium tuberculosis H37Rv incubated at 37 degC for 7 days by microplate alamar blue assay2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID214230Tested for in vitro cytotoxic activity against CNS U251 human cancer cell lines2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationship.
AID1461749Antiproliferative activity against human K562 cells after 48 hrs by MTT staining-based method2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID674375Cytotoxicity against human Bel7402 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID722035Therapeutic index, ratio of TD50 for human foreskin fibroblast cells to ID 50 for Toxoplasma gondii2013Bioorganic & medicinal chemistry letters, Feb-15, Volume: 23, Issue:4
Tryptanthrin derivatives as Toxoplasma gondii inhibitors--structure-activity-relationship of the 6-position.
AID674862Inhibition of calf thymus DNA topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 20 uM after 30 mins by agarose gel electrophoresis analysis2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Synthesis of benzo-annulated tryptanthrins and their biological properties.
AID481432Antibacterial activity against Escherichia coli AS19 assessed as growth inhibition at 10 ug/ml after 4 hrs2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antimicrobial activity of tryptanthrins in Escherichia coli.
AID602119NOVARTIS: Antimalarial liver stage activity measured as reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells by immuno-fluorescence, and median schizont size at 10uM compound concentration2011Science (New York, N.Y.), Dec-09, Volume: 334, Issue:6061
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
AID1461741Antiproliferative activity against human K562 cells after 24 hrs2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID739535Antitubercular activity against Mycobacterium tuberculosis H37Rv incubated at 37 degC for 14 days in presence of 40% human serum by microplate alamar blue assay2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID1243389Antimycobacterial activity against Mycobacterium tuberculosis H37Rv2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents.
AID481424Antibacterial activity against Escherichia coli AS19 after 4 hrs2010Journal of medicinal chemistry, May-13, Volume: 53, Issue:9
Antimicrobial activity of tryptanthrins in Escherichia coli.
AID449704NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay2008Proceedings of the National Academy of Sciences of the United States of America, Jul-01, Volume: 105, Issue:26
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
AID1585054Uncompetitive inhibition of recombinant full length C-terminal His-tagged human TDO expressed in Escherichia coli using L-Trp as substrate after 30 mins by Dixon plot analysis2018European journal of medicinal chemistry, Dec-05, Volume: 160Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives.
AID1377578Inhibition of P-gp in human Caco2 cells assessed as reduction in digoxin efflux at 4 uM relative to control2017European journal of medicinal chemistry, Sep-29, Volume: 138Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
AID1461753Inhibition of PMA-induced HGF production in HDF at 0.1 mg/ml after 24 hrs by ELISA2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID739218Half life in female rat at 56 mg/kg, po2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID717352Inhibition of COX2 in lipopolysaccharide-stimulated human MONO-MAC-6 cells2012Bioorganic & medicinal chemistry, Dec-15, Volume: 20, Issue:24
Analogue-based design, synthesis and docking of non-steroidal anti-inflammatory agents. Part 2: methyl sulfanyl/methyl sulfonyl substituted 2,3-diaryl-2,3-dihydro-1H-quinazolin-4-ones.
AID102522Tested for in vitro cytotoxic activity against lung H522 human cancer cell lines2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationship.
AID403340Inhibition of COX22005Journal of natural products, Jul, Volume: 68, Issue:7
Expanding the ChemGPS chemical space with natural products.
AID674868Cytotoxicity against human HEK293 cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Synthesis of benzo-annulated tryptanthrins and their biological properties.
AID1703859Inhibition of human DNA topoisomerase 2alpha assessed as suppression of decatenation using catenated kinetoplast DNA as substrate up to 250 uM measured after 30 mins by SYBR safe DNA staining based staining-based agarose gel electrophoresis method2020European journal of medicinal chemistry, Sep-15, Volume: 202Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer.
AID1179029Induction of BMP2 gene expression in C3H/He mouse P19CL6 cells at 1 uM measured on day 10 and 18 by RT-PCR analysis2014Journal of natural products, Jun-27, Volume: 77, Issue:6
8-Methyltryptanthrin-induced differentiation of P19CL6 embryonal carcinoma cells into spontaneously beating cardiomyocyte-like cells.
AID104219Tested for in vitro cytotoxic activity against melanoma M14 human cancer cell lines2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationship.
AID739220Cmax in female rat at 56 mg/kg, po2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID739537Aqueous solubility in PBS buffer at pH 7.4 by HPLC method2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID1530262Binding affinity to human full-length JNK2 (M1 to Q382 residues) expressed in HEK293 cells at <40 uM after 1 hr by Kinomescan method2019European journal of medicinal chemistry, Jan-01, Volume: 161Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
AID1612291Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 1 week by MABA2019Journal of natural products, 03-22, Volume: 82, Issue:3
Isolation of Tryptanthrin and Reassessment of Evidence for Its Isobaric Isostere Wrightiadione in Plants of the Wrightia Genus.
AID1461747Antiproliferative activity against human K562 cells after 48 hrs2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1461771Antiproliferative activity against spleen cells from SBP-immunized mouse assessed as fluorescence intensity at 10 uM after 3 days by Alamar blue dye-based method (Rvb = 2781 +/- 59 No_unitI)2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID674863Inhibition of human DNA topoisomerase 2alpha-mediated relaxation of supercoiled pBR322 DNA at 100 uM after 30 mins by agarose gel electrophoretic analysis2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Synthesis of benzo-annulated tryptanthrins and their biological properties.
AID739222Efflux ratio in human Caco2 cells incubated for 1 hr at 37 degC by HPLC-MS/MS method2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID674865Cytotoxicity against human T47D cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Synthesis of benzo-annulated tryptanthrins and their biological properties.
AID674866Cytotoxicity against human HCT15 cells after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Synthesis of benzo-annulated tryptanthrins and their biological properties.
AID1243391Antimycobacterial activity against Mycobacterium smegmatis2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents.
AID1053473Mixed competitive inhibition of human recombinant IDO1 using L-tryptophan as substrate2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
AID722037Antimicrobial activity against Toxoplasma gondii assessed as inhibition of growth measured after 5 days by beta-galactosidase assay2013Bioorganic & medicinal chemistry letters, Feb-15, Volume: 23, Issue:4
Tryptanthrin derivatives as Toxoplasma gondii inhibitors--structure-activity-relationship of the 6-position.
AID405962Cytotoxicity against human NCI-H460 cells2008Journal of natural products, Jul, Volume: 71, Issue:7
Isolation, structure elucidation, and synthesis of cytotoxic tryptanthrin analogues from Phaius mishmensis.
AID739524Inhibition of human recombinant CYP3A4 at 10 uM incubated for 30 mins at 37 degC using 7-benzyloxy-4-(trifluoromethyl)coumarin substrate2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID1461758Cytotoxicity against human wild-type MCF7 cells after 72 hrs2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID739221Cmax in male rat at 56 mg/kg, po2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID532592Therapeutic index, ration of TD50 for human foreskin fibroblast cell infected with Toxoplasma gondii to ID 50 for Toxoplasma gondii2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs.
AID449703NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay 2008Proceedings of the National Academy of Sciences of the United States of America, Jul-01, Volume: 105, Issue:26
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
AID1179044Induction of differentiation of C3H/He mouse P19CL6 cells assessed as beating aggregate formation at 0.1 to 1 uM on day 10 by phase contrast microscopic analysis2014Journal of natural products, Jun-27, Volume: 77, Issue:6
8-Methyltryptanthrin-induced differentiation of P19CL6 embryonal carcinoma cells into spontaneously beating cardiomyocyte-like cells.
AID739529Protein binding in human plasma at 10 uM incubated for 8 hrs at 37 degC by equilibrium dialysis method2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID532590Cytotoxicity against human foreskin fibroblast cell infected with Toxoplasma gondii2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs.
AID1461764Inhibition of 5-LO in LPS-stimulated human neutrophils by HPLC analysis2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID449705NOVARTIS: Cytotoxicity against human hepatocellular carcinoma cell line (Huh7)2008Proceedings of the National Academy of Sciences of the United States of America, Jul-01, Volume: 105, Issue:26
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
AID1377579Inhibition of MRP2 in human Caco2 cells assessed as reduction in pravastatin sodium efflux at 4 uM relative to control2017European journal of medicinal chemistry, Sep-29, Volume: 138Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.
AID1053471Inhibition of human IDO1 expressed in HEK293 cells assessed as kynurenine release after 5 hrs by spectrophotometry2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
AID1053469DPPH radical scavenging activity assessed as reducing ability at 5 to 100 uM after 30 mins by spectrophotometry2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
AID1703861Antiproliferative activity against human CCRF-CEM cells assessed as reduction in cell viability after 72 hrs by eosin exclusion dye based light microscopic method2020European journal of medicinal chemistry, Sep-15, Volume: 202Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer.
AID1612292Cytotoxicity against African green monkey Vero cells by CellTiter 96 aqueous nonradioactive cell proliferation assay2019Journal of natural products, 03-22, Volume: 82, Issue:3
Isolation of Tryptanthrin and Reassessment of Evidence for Its Isobaric Isostere Wrightiadione in Plants of the Wrightia Genus.
AID1585056Inhibition of TDO in human U87 MG cells using L-Trp as substrate after 8 hrs2018European journal of medicinal chemistry, Dec-05, Volume: 160Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives.
AID674373Cytotoxicity against human BGC823 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1461752Induction of apoptosis in human K562 cells assessed as late apoptotic cells at 25 ug/ml by Annexin V/propidium iodide staining-based flow cytometry2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1530269Binding affinity to human partial length TRKA (G475 to G790 residues) expressed in HEK293 cells measured after 1 hr by Kinomescan method2019European journal of medicinal chemistry, Jan-01, Volume: 161Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
AID1179041Induction of Cav1.2 gene expression in C3H/He mouse P19CL6 cells2014Journal of natural products, Jun-27, Volume: 77, Issue:6
8-Methyltryptanthrin-induced differentiation of P19CL6 embryonal carcinoma cells into spontaneously beating cardiomyocyte-like cells.
AID674869Cytotoxicity against human HT-1376 cells2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Synthesis of benzo-annulated tryptanthrins and their biological properties.
AID739538Distribution coefficient, log D of the compound between n-octanol and PBS buffer at pH 7.4 incubated for 1 hr by shake flask method2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID739219Half life in male rat at 56 mg/kg, po2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID1530258Binding affinity to human full-length JNK1 (M1 to Q384 residues) expressed in HEK293 cells measured after 1 hr by Kinomescan method2019European journal of medicinal chemistry, Jan-01, Volume: 161Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
AID1179028Induction of GATA4 gene expression in C3H/He mouse P19CL6 cells at 1 uM measured on day 10 and 18 by RT-PCR analysis2014Journal of natural products, Jun-27, Volume: 77, Issue:6
8-Methyltryptanthrin-induced differentiation of P19CL6 embryonal carcinoma cells into spontaneously beating cardiomyocyte-like cells.
AID1179020Induction of differentiation of C3H/He mouse P19CL6 cells assessed as aggregate formation at 0.1 to 1 uM on day 10 by phase contrast microscopic analysis2014Journal of natural products, Jun-27, Volume: 77, Issue:6
8-Methyltryptanthrin-induced differentiation of P19CL6 embryonal carcinoma cells into spontaneously beating cardiomyocyte-like cells.
AID449706NOVARTIS: Inhibition Frequency Index (IFI) - the number of HTS assays where a compound showed > 50% inhibition/induction, expressed as a percentage of the number of assays in which the compound was tested.2008Proceedings of the National Academy of Sciences of the United States of America, Jul-01, Volume: 105, Issue:26
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen.
AID532591Antimicrobial activity against Toxoplasma gondii2008Antimicrobial agents and chemotherapy, Dec, Volume: 52, Issue:12
Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs.
AID1202798Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2015Journal of medicinal chemistry, Apr-23, Volume: 58, Issue:8
Antimalarial activity of 4-amidinoquinoline and 10-amidinobenzonaphthyridine derivatives.
AID1585057Inhibition of TDO (unknown origin) expressed in HEK293 cells using L-Trp as substrate after 8 hrs2018European journal of medicinal chemistry, Dec-05, Volume: 160Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives.
AID674371Antiviral activity against Herpes simplex virus 1 at 10 uM2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1461746Inhibition of IDO-1 (unknown origin)2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID674370Antiviral activity against HIV1 infected in 293T cells cotransfected with VSV-G at 10 uM after 48 hrs by ELISA2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1461770Antiproliferative activity against spleen cells from SBP-immunized mouse assessed as fluorescence intensity at 5 uM after 3 days by Alamar blue dye-based method (Rvb = 2781 +/- 59 No_unitI)2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1332703Uncompetitive inhibition of recombinant human C-terminal His6-tagged IDO2 (14-420 residues) expressed in Escherichia coli BL21(DE3) in presence of varying concentration of L-tryptophan substrate after 30 mins2016European journal of medicinal chemistry, Nov-10, Volume: 123Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.
AID674374Cytotoxicity against human MCF7 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID1179027Induction of alpha-MHC gene expression in C3H/He mouse P19CL6 cells at 1 uM measured on day 10 and 18 by RT-PCR analysis2014Journal of natural products, Jun-27, Volume: 77, Issue:6
8-Methyltryptanthrin-induced differentiation of P19CL6 embryonal carcinoma cells into spontaneously beating cardiomyocyte-like cells.
AID1461765Inhibition of 5-LO in fMLP-stimulated human neutrophils by HPLC analysis2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1461772Antifungal activity against Malassezia furfur after 2 to 4 days by agar plate dilution method2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1461751Induction of apoptosis in human K562 cells assessed as late apoptotic cells at 12.5 ug/ml by Annexin V/propidium iodide staining-based flow cytometry2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID200265Tested for in vitro cytotoxic activity against ovarian SKOV3 human cancer cell lines2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationship.
AID1461767Anti-inflammatory activity in Wistar Han rat assessed as reduction of carrageenan-induced pleural LTB4 levels at 10 mg/kg, po administered 1 hr prior to carrageenan challenge by HPLC analysis2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1332710Reversible inhibition of recombinant human C-terminal His6-tagged IDO2 (14-420 residues) expressed in Escherichia coli BL21(DE3) assessed as reduction in L-kynurenine formation using L-tryptophan as substrate after 30 mins2016European journal of medicinal chemistry, Nov-10, Volume: 123Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.
AID739532Solubility in simulated intestinal fluid at pH 7.6 by HPLC method2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID674859Inhibition of COX22012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Synthesis of benzo-annulated tryptanthrins and their biological properties.
AID1461744Antiproliferative activity against human HL60 cells after 48 hrs2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID1461743Antiproliferative activity against human HL60 cells after 24 hrs2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID739531Solubility in simulated gastric fluid at pH 1.5 by HPLC method2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID674860Inhibition of 5-lipoxygenase2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Synthesis of benzo-annulated tryptanthrins and their biological properties.
AID739527Permeability across basolateral to apical side in human Caco2 cells incubated for 1 hr at 37 degC by HPLC-MS/MS method2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID674858Antituberculosis activity against Mycobacterium tuberculosis2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Synthesis of benzo-annulated tryptanthrins and their biological properties.
AID202359Tested for in vitro cytotoxic activity against colon SW620 human cancer cell lines2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationship.
AID1053470Antiproliferative activity against mouse LLC cells at 50 uM by WST-1 assay2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
AID674376Cytotoxicity against human Ketr3 cells at 10 uM after 96 hrs by MTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Alkaloids from the root of Isatis indigotica.
AID161226Tested for in vitro cytotoxic activity against prostate DU145 human cancer cell lines2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationship.
AID1243390Antimycobacterial activity against Mycobacterium avium2015Bioorganic & medicinal chemistry letters, Sep-15, Volume: 25, Issue:18
Synthesis and biological evaluation of phaitanthrin congeners as anti-mycobacterial agents.
AID1461773Antibacterial activity against methicillin resistant Staphylococcus aureus after 24 hrs by agar plate dilution method2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID722036Cytotoxicity against human foreskin fibroblast cells by colorimetric method2013Bioorganic & medicinal chemistry letters, Feb-15, Volume: 23, Issue:4
Tryptanthrin derivatives as Toxoplasma gondii inhibitors--structure-activity-relationship of the 6-position.
AID1461759Cytotoxicity against human MCF7/ADR cells after 72 hrs2017Bioorganic & medicinal chemistry, 09-01, Volume: 25, Issue:17
Recent synthetic and medicinal perspectives of tryptanthrin.
AID103784Tested for in vitro cytotoxic activity against breast MCF-7/ADR human cancer cell lines2002Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17
Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure-activity relationship.
AID739530Metabolic stability in human liver microsomes assessed as parent compound remaining at 1 uM incubated for 1 hr by HPLC-MS/MS method2013Journal of natural products, Mar-22, Volume: 76, Issue:3
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
AID602118NOVARTIS: Antimalarial liver stage activity measured as a greater than 50% reduction in Plasmodium yoelii schizont area in HepG2-A16-CD81 cells at 10uM compound concentration, determined by immuno-fluorescence.2011Science (New York, N.Y.), Dec-09, Volume: 334, Issue:6061
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
AID405963Cytotoxicity against human SF268 cells2008Journal of natural products, Jul, Volume: 71, Issue:7
Isolation, structure elucidation, and synthesis of cytotoxic tryptanthrin analogues from Phaius mishmensis.
AID674861Inhibition of calf thymus DNA topoisomerase 1-mediated relaxation of supercoiled pBR322 DNA at 100 uM after 30 mins by agarose gel electrophoresis analysis2012Bioorganic & medicinal chemistry, Aug-15, Volume: 20, Issue:16
Synthesis of benzo-annulated tryptanthrins and their biological properties.
AID1332706Inhibition of recombinant human C-terminal His6-tagged IDO2 (14-420 residues) expressed in Escherichia coli BL21(DE3) assessed as reduction in L-kynurenine formation using L-tryptophan as substrate after 30 mins in presence of catalase by methylene blue d2016European journal of medicinal chemistry, Nov-10, Volume: 123Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.
AID1159589Biochemical screen of P. falciparum MAPK22016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159586Biochemical screen of P. falciparum PK62016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159587Biochemical screen of P. falciparum PK72016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159588Biochemical screen of P. falciparum CDPK42016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID1159585Biochemical screen of P. falciparum CDPK12016PloS one, , Volume: 11, Issue:3
Biochemical Screening of Five Protein Kinases from Plasmodium falciparum against 14,000 Cell-Active Compounds.
AID602156Novartis GNF Liver Stage Dataset: Malariabox Annotation2011Science (New York, N.Y.), Dec-09, Volume: 334, Issue:6061
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1346186Human indoleamine 2,3-dioxygenase 1 (1.13.11.- Dioxygenases)2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (131)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (0.76)18.7374
1990's1 (0.76)18.2507
2000's35 (26.72)29.6817
2010's71 (54.20)24.3611
2020's23 (17.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.54

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.54 (24.57)
Research Supply Index4.92 (2.92)
Research Growth Index6.03 (4.65)
Search Engine Demand Index44.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.54)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.74%)5.53%
Reviews5 (3.70%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other129 (95.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]